Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Autor: Angela Williard, Sara L. Pressel, Lara M. Simpson, Connie Kingry, Karen L. Margolis, Michael A. Proschan, Juan Alzate, Frans H. H. Leenen, Jeff D. Williamson, Robert Pospisil, John H. Eckfeldt, David C. Goff, I. Kay Dunn, L. Julian Haywood, Suzanne Oparil, Gail T. Louis, Michael H. Alderman, Paul K. Whelton, R. L Sue Ferguson, Anne Juratovac, Brenda Jaeger, David Gordon, Pamela Ragusa, Richard S. Crow, David A. Calhoun, Christine Nelson, Jeanne Russo, William C. Cushman, Therese S. Geraci, Linda B. Piller, Sharon Feldman, Tracy Lucente, Gail Barone, Judy Bettencourt, Kim Jenkins, Peggy McDowell, Lillian Carroll, Jeffrey A. Cutler, Henry R. Black, Jackson T. Wright, Sandra M. Walsh, Joe Blanton, Sheila Sullivan, Rudy Christian, John Pelosi, Richard H. Grimm, Joanna Tanner, Curt D. Furberg, Barbara DeLeon, Janice Johnson, Paula Einhom, Leslie Ann Holland-Klemme, Barry R. Davis, Mahboob Rahman, Jeffrey L. Probstfield, Chuke Nwachuku, Charles E. Ford

Publikováno v: JAMA: The Journal of the American Medical Association. 288:2981-2997

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e7cc7c3bb46bd6d64a64ff24495784d3
https://doi.org/10.1001/jama.288.23.2981